No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
DVA240517C150000
- 0.15
- +0.05+50.00%
15min DelayClose May 10 16:00 ET
0.34High0.15Low
0.34Open0.10Pre Close31 Volume886 Open Interest150.00Strike Price484.00Turnover38.83%IV9.18%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.15Time Value100Contract SizeAmericanOptions Type0.0512Delta0.0148Gamma916.80Leverage Ratio-0.0541Theta0.0012Rho46.93Eff Leverage0.0193Vega
Intraday
- 5D
- 1D
News
Form 144 | DaVita(DVA.US) Officer Proposes to Sell 693.84K in Common Stocks
SEC FILLINGS DISCLOSED/ May 10, $DaVita(DVA.US)$ Officer DESOER BARBARA J intends to sell 5,030 shares of its common stock on May 10, with a total market value of approximately $693.84K. Source: An
Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) Is a Great Choice
DaVita Honors 54 Nephrology Nurses With DAISY Awards
Award celebrates excellence in nursing, underscoring the kidney care provider's commitment to recognizing the indelible impact of clinicians on outstanding patient care DENVER, May 9, 2024 /PRNewswire
DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference
DENVER, May 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will parti
4 Stocks to Buy in a Thriving Outpatient Home Health Industry
The Zacks Analyst Blog Highlights DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant
Comments
DaVita's global expansion strategy, backed by strong local team investment, is set to make a lasting impact on healthcare communities. Their focus remains on providing exceptional care for kidney disease patients.
Press Release: DaVita Enters Into Agreement to Expand Operations in Brazil and Colombia, Enter Chile and Ecuador 1
Legendary INvestor Warrent BUffett Portfolio
$Apple(AAPL.US$ $Bank of America(BAC.US$ $American Express(AXP.US$ $Coca-Cola(KO.US$ $CHERVON(02285.HK$ $The Kraft Heinz(KHC.US$ $Moody's(MCO.US$ $DaVita(DVA.US$ $CITIC BANK(00998.HK$
$Apple(AAPL.US$ $Bank of America(BAC.US$ $American Express(AXP.US$ $Coca-Cola(KO.US$ $CHERVON(02285.HK$ $The Kraft Heinz(KHC.US$ $Moody's(MCO.US$ $DaVita(DVA.US$ $CITIC BANK(00998.HK$
5
Analysts believe DaVita's strong Q4 financials and full-year outlook were driven by expected volume improvements and continued strong cost controls. However, some analysts maintain a cautious stance, waiting to see more proof points on volume improvement.
1
DaVita's shares are a bargain per the price multiple model. High beta indicates a potential fall in a bearish market, offering a prime buying opportunity. Expected profit growth promises a bright future, leading to higher cash flow and share valuation.
DaVita's current P/E ratio implies investors doubt the company's future growth prospects. Unobserved earnings threats may be hindering the positive outlook typically reflected in the P/E ratio.
1
Read more